Brief: Absci Corp Expects To Initiate Investigational New Drug Application Enabling Studies For Abs-101 In Feb 2024
Jan 8 (Reuters) - Absci Corp ABSI.O :
* ABSCI CORP: EXPECTS TO INITIATE INVESTIGATIONAL NEW DRUG
APPLICATION (IND) ENABLING STUDIES FOR ABS-101 IN FEB 2024, AND
SUBMIT AN IND IN Q1 2025
Source text for Eikon: ID:nGNX2Dtq2s
Further company coverage: ABSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbSci
See all newsAbsci Corp reports results for the quarter ended September 30 - Earnings Summary
Brief: Absci Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing
Absci Q3 revenue misses estimates, net loss widens on R&D spends
Focus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave